• 1
    UNAIDS 2002 [monograph online]. Available from URL:
  • 2
    Cote TR, Biggar RJ, Rosenberg PS, et al. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer. 1997; 73: 645650.
  • 3
    Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. AIDS-Cancer Match Registry Study Group. JAMA. 2001; 285: 17361745.
  • 4
    Dal Maso L, Serraino D, Franceschi S. Epidemiology of AIDS-related tumors in developed and developing countries. Eur J Cancer. 2001; 37: 11881201.
  • 5
    Frisch M, Biggar RJ, Goedert JJ. Human-papillomavirus-associated cancers in patients with human-immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000; 92: 15001510.
  • 6
    Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi sarcoma and non-Hodgkin lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002; 94: 12041210.
  • 7
    Mbulaiteye SM, Parkin DM, Rabkin S. Epidemiology of AIDS-related malignancies. An international perspective. Hematol Oncol Clin North Am. 2003; 17: 673696.
  • 8
    Bhoopat L, Thamprasert K, Chaiwun B, et al. Histopathologic spectrum of AIDS-associated lesions in Maharaj Nakorn Chiang Mai Hospital. Asian Pac J Allergy Immunol. 1994; 12: 95104.
  • 9
    Bhoopat SK, Vithayasai P, Pruksachatkunakorn C. AIDS-associated Kaposi sarcoma: a rare entity at Maharaj Nakorn Chiang Mai Hospital. Asian Pac J Allergy Immunol. 1996; 14: 115120.
  • 10
    Sanpakit K, Veerakul G, Kriengsuntornkij W, Chokephaibulkit K, Tanphaichitr VS, Mahasandana C. Malignancies in HIV-infected children at Siriraj Hospital. J Med Assoc Thai. 2002; 85 Suppl 2: S542S548.
  • 11
    Nittayananta W, Chungpanich S. Oral lesions in a group of Thai people with AIDS. Oral Dis. 1997; 3 Suppl 1: S41S45.
  • 12
    Chotmongkol V, Pesee M. AIDS-related primary central nervous system lymphoma: prolonged remission associated with highly active antiretroviral therapy. J Med Assoc Thai. 2002; 85: 634637.
  • 13
    Deerasamee S, Martin N, Sontipong S, et al. Cancer registration in Thailand. Asia Pac J Cancer Prev. 2001; 2 Suppl 1: 7984.
  • 14
    Deerasamee S, Martin N, Sontipong S, et al. Cancer in Thailand. Volume II: 1992-1994. IARC Technical Report No. 34. Lyon: International Agency for Research on Cancer, 1999.
  • 15
    PercyC, Van HoltenV, MuirC, editors. International classification of diseases for oncology (2nd edition). Geneva: World Health Organization, 1990.
  • 16
    Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst. 2000; 92: 12401251.
  • 17
    Biggar RJ. AIDS-related cancers in the era of highly active anti-retroviral therapy. Oncology. 2001; 15: 439449.
  • 18
    National Statistical Office of Thailand. 1990 population and household census. Bangkok: National Statistical Office, 1992.
  • 19
    National Statistical Office of Thailand. 2000 population and household census. Available from URL:
  • 20
    Doll R, Cook P. Summarising indices for comparison of cancer incidence data. Int J Cancer. 1967; 2: 269279.
  • 21
    Joint United Nations Programme on HIV/AIDS. Epidemiology fact sheets on HIV/AIDS and sexually transmitted infection: Thailand 2004 [monograph online]. Available from URL:
  • 22
    Centers for Disease Control and Prevention. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men—New York City and California. MMWR Morb Mortal Wkly Rep. 1981; 30: 305308.
  • 23
    ParkinDM, WhelanSL, FerlayJ, TeppoL, ThomasDB, editors. Cancer incidence in five continents. Volume VIII. IARC Scientific Publication No. 155. Lyon: International Agency for Research on Cancer, 2002.
  • 24
    Peterman TA, Jaffe HW, Beral V. Epidemiologic clues to the etiology of Kaposi's sarcoma. AIDS. 1993; 7: 605611
  • 25
    Elford J, McDonald A, Kaldor J. Kaposi sarcoma as a sexually transmissible infection: an analysis of Australian AIDS surveillance data. The National HIV Surveillance Committee. AIDS. 1993; 7: 16671671.
  • 26
    Boshoff C, Weiss RA. Epidemiology and pathogenesis of Kaposi sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci. 2001; 356: 517534.
  • 27
    Engels EA, Whitby D, Goebel PB, et al. Identifying human herpesvirus 8 infection: performance characteristics of serological assays. J Acquir Immune Defic Syndr. 2000; 23: 346354.
  • 28
    Ablashi DV, Chatlynne LG, Whitman JE Jr., Cesarman E. Spectrum of Kaposi sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev. 2002; 15: 439464.
  • 29
    Ayuthaya PI, Katano H, Inagi R, et al. The seroprevalence of human herpesvirus 8 infection in the Thai population. Southeast Asian J Trop Med Public Health. 2002; 33: 297305.
  • 30
    Ablashi D, Chatlynne L, Cooper H, et al. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer. 1999; 81: 893897.
  • 31
    Grulich AE, Li Y, McDonald AM, Correll PK, Law MG, Kaldor JM. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS. 2001; 15: 629633.
  • 32
    Hartge P, Devesa SS, Fraumeni FJ Jr. Hodgkin and non-Hodgkin lymphoma. Cancer Surv. 1994; 19–20: 423453.
  • 33
    Sukpanichnant S, Sonakul D, Piankijagum A, et al. Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital. Cancer. 1998; 83: 11971204.
  • 34
    Remick SC. Acquired immunodeficiency syndrome-related non-Hodgkin lymphoma. Cancer Control. 1995; 2: 97103.
  • 35
    Cole P, MacMahon B. Attributable risk percent in case-control studies. Br J Prev Soc Med. 1971; 25: 242244.